| German Asthma Net: Nasal polyposis in patients with severe asthma | Christina Bal | ÖGP Congress,
Graz | 2023 |
| German Asthma Net: Characterization of responders of anti-IL5 and anti-IL5(R) therapy | Christina Bal | ÖGP Congress,
Graz | 2023 |
| Initiation, response assessment and switch of antibody therapies in patients with severe asthma - a survey among German specialists | Hendrik Suhling | ERS Congress,
Mailand | 2023 |
| German Asthma Net: Nasal polyposis in patients with severe asthma | Christina Bal | ERS Congress,
Mailand | 2023 |
| German Asthma Net: Characterization of responders of anti-IL5 and anti-IL5(R) therapy | Christina Bal | ERS Congress,
Mailand | 2023 |
| The impact of smoking history on baseline characteristic in patients with severe asthma in the German Asthma Net (GAN) | Leonie Biener | ERS Congress,
Mailand | 2023 |
| Impact of Smoking on biologicals treatment response from the German Severe Asthma (GAN) Registry | S. Stoshikj/ L. Biener/ D. Skowasch/ M. Idzko | ERS Congress,
Mailand | 2023 |
| The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort | Christina Bal | DGP Kongress,
Düsseldorf | 2023 |
| The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy | Christina Bal | DGP Kongress,
Düsseldorf | 2023 |
| Performance of pulmonary rehabilitation in a national severe asthma cohort | I. Jarosch | ATS Congress,
Washington, DC | 2023 |
| Bronchodilator reversibility in patients with severe asthma included in the GAN registry | K. Milger | ERS Kongress,
Barcelona | 2022 |
| AGE OF ASTHMA ONSET (Alter bei Beschwerde-Beginn [Diagnose]) | Marek Lommatzsch | ERS Kongress,
Barcelona | 2022 |
| The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort | Christina Bal | ERS Kongress,
Barcelona | 2022 |
| Bronchodilator reversibility in patients with severe asthma included in the GAN registry | Katrin Milger | DGP Kongress,
Leipzig | 2022 |
| Häufigkeit und Gründe der Biologika-Umstellung bei schwerem Asthma | Michael Gerstlauer/ Mandy Seefeldt | DGP Kongress,
Leipzig | 2022 |
| The Severe Asthma Registry of the German Asthma Net: protocol for a real-world study to describe the use of mepolizumab in clinical practice in Germany (MepoGAN-study) | Stephanie Korn | ERS Kongress,
virtuell | 2020 |
| The German Severe Asthma Registry: Obesity is associated with asthma parameters | Christina Bal | ERS Kongress,
virtuell | 2020 |
| Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort | Katrin Milger | ATS Kongress,
virtuell | 2020 |
| Alters- und geschlechtsabhängige Unterschiede von Patienten mit schwerem Asthma bronchiale im German Asthma Net | Katrin Milger | DGP Kongress | 2020 |
| The German Severe Asthma Registry and Type 2-high and Type 2-low asthma phenotypes | Stephanie Korn | ERS Kongress,
Madrid | 2019 |
| Real-life effectiveness of anti-IL-5 (receptor) antibody treatment in patients with severe eosinophilic asthma | Stephanie Korn | ERS Kongress,
Madrid | 2019 |
| The German Severe Asthma Registry: FeNO values correlate with medical therapy, quality of life and smoking | Christina Bal | ERS Kongress,
Madrid | 2019 |
| Type 2-high and Type 2-low Airway Inflammation in Severe Asthma | Stephanie Korn | ATS Kongress,
Dallas, TX | 2019 |
| The Severe Asthma Registry – German data | Stephanie Korn | ERS Kongress,
Paris | 2018 |
| Clusteranalysen an Querschnittsdaten chronisch erkrankter Patienten am Beispiel des Deutschen Registers Schweres Asthma | Johannes Holstege | GMDS 2015 | 2015 |
| Patients with allergic and eosinophilicasthma in the German Severe Asthma Registry | Johannes Holstege | ERS Kongress,
Amsterdam | 2015 |
| Allergic and eosinophilic phenotypes in the German Severe Asthma Registry | Stephanie Korn | ATS Kongress,
San Diego | 2014 |
| The German Severe Asthma Registry | Stephanie Korn | ERS Kongress,
Wien | 2012 |
